Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. Read more about Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy.
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. Read more about Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
Identifying the needs of brain tumor patients and their caregivers. Read more about Identifying the needs of brain tumor patients and their caregivers.
OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. Read more about OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms.
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. Read more about Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors. Read more about KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.
FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients. Read more about FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients.
Pathological classification and molecular genetics of meningiomas. Read more about Pathological classification and molecular genetics of meningiomas.
